Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta. The FDA approved low-dose, preservative-free Qlosi (pilocarpine HCl ophthalmic solution) 0.4% in October 2023 ...

Visionary Ventures, while also not securing deals in OC, recorded eight deals during 2024 that included $65 million financing into ONL Therapeutics, $78 million into Orasis Pharmaceuticals and $75 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo Former Republican Representative ...

New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large studies published in Investigative Ophthalmology & Visual Science ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Orasis Pharma meanwhile recently started a phase 3 programme for CSF-1, which combines pilocarpine with a lubricant to improve comfort and ease of use. LENZ Therapeutics (formerly Presbyopia ...